InsidersTradesSigma
Follow the SVAS BIOSANA stock price and the full management transaction log of the company, a listed equity based in Italy. Shares are quoted on the IT market, under the authority of Consob. Operating in the Health Care sector, SVAS BIOSANA has published 4 reports. Market capitalisation: €46.5m. The latest transaction was disclosed on 15 April 2025 (Other). The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
SVAS BIOSANA 是一家专注于医疗保健和制药领域的公司。该公司在 XMIL 市场上市。